Method for determination of sensitivity to anti-cancer agent

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/15 (2006.01) G01N 33/68 (2006.01) C07K 14/47 (2006.01) C07K 14/82 (2006.01)

Patent

CA 2713296

Provided are an marker for determining sensitivity to an anticancer agent capable of distinguishing a therapeutic response of an individual patient and a novel means for a cancer therapy using the marker. The marker for determining sensitivity to an anticancer agent contains a calcium-binding protein S100A7,S100A8, or S100A10.

La présente invention porte sur un marqueur servant à déterminer la sensibilité à un agent anticancéreux, pouvant permettre de déterminer la prise en charge thérapeutique chez des patients individuels. L'invention porte également sur un nouveau moyen de traitement du cancer utilisant ledit marqueur. L'invention concerne de manière spécifique un marqueur servant à déterminer la sensibilité à un agent anticancéreux, incluant une protéine liant le calcium S100A7, S100A8 ou S100A10.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for determination of sensitivity to anti-cancer agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for determination of sensitivity to anti-cancer agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determination of sensitivity to anti-cancer agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1929750

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.